Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-04 1:43 pm Purchase |
2024-09-30 | 13G | Luxfer Holdings PLC LXFR |
The Vanguard Group | 1,726,334 6.300% |
1,726,334 (New Position) |
Filing History |
| 2024-11-04 1:43 pm Purchase |
2024-09-30 | 13G | Ocugen, Inc. OCGN |
The Vanguard Group | 16,949,019 5.880% |
4,909,101 (+40.77%) |
Filing History |
| 2024-11-04 1:43 pm Purchase |
2024-09-30 | 13G | Klaviyo, Inc. KVYO |
The Vanguard Group | 7,075,227 9.740% |
4,971,514 (+236.32%) |
Filing History |
| 2024-11-04 1:43 pm Sale |
2024-09-30 | 13G | Luna Innovations Incorporated LUNA |
The Vanguard Group | 1,668,913 4.910% |
-160,987 (-8.80%) |
Filing History |
| 2024-11-04 1:43 pm Purchase |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
The Vanguard Group | 2,802,965 5.080% |
2,802,965 (New Position) |
Filing History |
| 2024-11-04 1:43 pm Purchase |
2024-09-30 | 13G | Claritev Corporation CTEV |
The Vanguard Group | 334,067 2.060% |
334,067 (New Position) |
Filing History |
| 2024-11-04 1:42 pm Sale |
2024-09-30 | 13G | Planet Labs PBC PL |
The Vanguard Group | 15,555,241 5.710% |
-2,721,001 (-14.89%) |
Filing History |
| 2024-11-04 1:42 pm Purchase |
2024-09-30 | 13G | Nextracker Inc. NXT |
The Vanguard Group | 13,600,362 9.480% |
8,890,204 (+188.75%) |
Filing History |
| 2024-11-04 1:42 pm Sale |
2024-09-30 | 13G | Leslie's, Inc. LESL |
The Vanguard Group | 16,125,657 8.720% |
-2,991,192 (-15.65%) |
Filing History |
| 2024-11-04 1:42 pm Purchase |
2024-09-30 | 13G | nCino, Inc. NCNO |
The Vanguard Group | 9,882,491 8.550% |
2,908,159 (+41.70%) |
Filing History |
| 2024-11-04 1:42 pm Sale |
2024-09-30 | 13G | PROG Holdings, Inc. PRG |
The Vanguard Group | 4,860,398 11.480% |
-777,833 (-13.80%) |
Filing History |
| 2024-11-04 1:42 pm Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
The Vanguard Group | 8,384,183 5.370% |
3,266,081 (+63.81%) |
Filing History |
| 2024-11-04 1:42 pm Purchase |
2024-09-30 | 13G | NXP Semiconductors N.V. NXPI |
The Vanguard Group | 13,222,354 5.190% |
13,222,354 (New Position) |
Filing History |
| 2024-11-04 1:41 pm Purchase |
2024-09-30 | 13G | Ouster, Inc. OUST |
The Vanguard Group | 3,478,944 7.190% |
1,314,481 (+60.73%) |
Filing History |
| 2024-11-04 1:41 pm Purchase |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
The Vanguard Group | 1,038,994 5.850% |
1,038,994 (New Position) |
Filing History |
| 2024-11-04 1:41 pm Sale |
2024-09-30 | 13G | Mural Oncology plc MURA |
The Vanguard Group | 835,589 4.900% |
-688,428 (-45.17%) |
Filing History |
| 2024-11-04 1:41 pm Purchase |
2024-09-30 | 13G | Oscar Health, Inc. OSCR |
The Vanguard Group | 18,411,347 8.920% |
4,166,435 (+29.25%) |
Filing History |
| 2024-11-04 1:33 pm Unchanged |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
The Vanguard Group | 13,043,077 6.640% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:33 pm Unchanged |
2024-09-30 | 13G | Hims & Hers Health, Inc. HIMS |
The Vanguard Group | 18,236,394 8.730% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:31 pm Unchanged |
2024-09-30 | 13G | Fox Factory Holding Corp. FOXF |
The Vanguard Group | 4,633,799 11.110% |
0 (Unchanged) |
Filing History |